At a glance
- Originator Abbott Laboratories
- Class Neuroprotectants; Nootropics
- Mechanism of Action Muscarinic M1 receptor agonists; Muscarinic M2 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease